patent/MX-342181-B

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-342181-B

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f26dbe20d4266eacb686db68d52c2048
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-765 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-765 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate	2011-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f219b0aee8cd15b5dba050b59bce2ed http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4bd57a322dfceb7d93e859799c407be http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0671c153232eab14b9454664cfd71adf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdfe89b13735e86d8455df47bd5862dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f523c98c1f690d5e4be8a1be232cb57
publicationDate	2016-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	MX-342181-B
titleOfInvention	FORMULATIONS THAT INCLUDE POLYETHYLENE GLYCOL.
abstract	The present invention relates to a solid formulation for oral administration as a solid comprising polyethylene glycol and an additional solid such as mannitol. The formulation can be used to prevent gastrointestinal disorders such as constipation in healthy subjects. In some embodiments, the solid formulation is for chewing or sucking.
priorityDate	2010-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805

Total number of triples: 34.